Hepatic Cancer
33
6
8
13
Key Insights
Highlights
Success Rate
68% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
18.2%
6 terminated out of 33 trials
68.4%
-18.1% vs benchmark
6%
2 trials in Phase 3/4
31%
4 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (33)
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
RCT of Mobile Apps & FitBit v. Usual Care
Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation
Bleeding in Laparoscopic Liver Surgery
A Study of CDX-585 in Patients With Advanced Malignancies
Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
The Registry of Oncology Outcomes Associated with Testing and Treatment
Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation
Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy
LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic Tumors
Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.
Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma
Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC)
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies